Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BHC.TOthis companyBausch Health Companies Inc.	CA$11.64	16.14×	-4.65×	0.25×	6.55×	2885.5%	60.9%	21.3%	1.5%	-28.9%	3.2%	37.9%	-38.35×	5.8×	1.35×	1.47×	0.0%	5	0.45	2	C
CPH.TOCipher Pharmaceuticals Inc.	CA$13.51	10.06×	2.22×	5.44×	11.52×	423.7%	65.8%	32.7%	54.2%	22.1%	12.8%	10.8%	0.04×	-0.08×	14.17×	1.12×	0.0%	6	9.06	5	S-
CRON.TOCronos Group Inc.	CA$5.25	-104.44×	0.92×	6.74×	-73.63×	-294.2%	41.4%	-12.0%	-6.4%	-0.9%	-0.3%	0.0%	0×	268.35×	0×	19.59×	0.0%	6	13.62	4	A-
EPIC.CN1CM Inc.	CA$0.18	57.32×	0.96×	0.38×	8.88×	-5639.8%	9.1%	2.2%	0.7%	1.7%	3.2%	9.1%	0.12×	-0.71×	1.88×	3.17×	0.0%	4	2.78	—	—
RX.VBioSyent Inc.	CA$17.95	15.91×	3.46×	3.33×	10.19×	15.5%	74.6%	26.3%	20.9%	21.7%	20.0%	6.7%	0.02×	-1.6×	229.23×	5.51×	1.6%	5	10.66	4	A
TLRY.TOTilray Brands, Inc.	CA$4.06	-5.04×	0.38×	0.67×	61.08×	-3328.0%	26.3%	-6.0%	-13.3%	-7.5%	-2.7%	-16.6%	0.25×	13.16×	-2.31×	2.21×	0.0%	4	-2.19	2	C+
Peer median	—	10.06×	0.96×	3.33×	10.19×	-294.2%	41.4%	2.2%	0.7%	1.7%	3.2%	6.7%	0.04×	-0.08×	1.88×	3.17×	0.0%	5	9.06	4	—